Adrienne Lapidos1, Kristen M Abraham2, Jennifer Jagusch3, James Garlick3, Heather Walters3, H Myra Kim4, Eduardo Vega5, Laura Damschroder6, Jane Forman6, Brian Ahmedani7, Cheryl A King8, Paul N Pfeiffer3. 1. University of Michigan Medical School, Department of Psychiatry, Ann Arbor, MI, United States. Electronic address: alapidos@umich.edu. 2. VA Center for Clinical Management Research, Ann Arbor, MI, United States; University of Detroit Mercy, Department of Psychology, Detroit, MI, United States. 3. University of Michigan Medical School, Department of Psychiatry, Ann Arbor, MI, United States; VA Center for Clinical Management Research, Ann Arbor, MI, United States. 4. VA Center for Clinical Management Research, Ann Arbor, MI, United States; Consulting for Statistics, Computing & Analytics Research, University of Michigan, Ann Arbor, MI, United States. 5. Humannovations, Los Angeles, CA, United States. 6. VA Center for Clinical Management Research, Ann Arbor, MI, United States. 7. Henry Ford Health System, Detroit, MI, United States. 8. University of Michigan Medical School, Department of Psychiatry, Ann Arbor, MI, United States.
Abstract
RATIONALE: Novel approaches to suicide prevention are needed to address increasing rates of suicide deaths. Research suggests that interventions led by certified Peer Specialists may improve suicide protective factors such as hope and connectedness; however, the effectiveness of a Peer Specialist intervention for reducing suicidal thoughts or behaviors has not previously been tested empirically. DESIGN: We describe the methodology of a randomized controlled hybrid effectiveness-implementation trial of a peer specialist intervention known as PREVAIL (Peers for Valued Living). The primary effectiveness aim is to determine whether the 3-month peer mentorship intervention compared to a minimally enhanced usual care condition reduces suicide attempts and suicidal ideation among adults at high risk for suicide who have been psychiatrically hospitalized. Secondary effectiveness outcomes include medically serious suicide attempts according to chart review and self-reported self-efficacy to avoid suicide. We also describe suicide risk management, supervision, and fidelity monitoring in the context of Peer Specialist providers and our methods for assessing implementation barriers and facilitators. CONCLUSION: The PREVAIL trial will demonstrate novel methods for incorporating peer providers into a suicide prevention effectiveness trial with high-risk study participants. PREVAIL's hybrid effectiveness-implementation design aims to maximize the likelihood of rapid implementation in the community if shown to be effective.
RCT Entities:
RATIONALE: Novel approaches to suicide prevention are needed to address increasing rates of suicide deaths. Research suggests that interventions led by certified Peer Specialists may improve suicide protective factors such as hope and connectedness; however, the effectiveness of a Peer Specialist intervention for reducing suicidal thoughts or behaviors has not previously been tested empirically. DESIGN: We describe the methodology of a randomized controlled hybrid effectiveness-implementation trial of a peer specialist intervention known as PREVAIL (Peers for Valued Living). The primary effectiveness aim is to determine whether the 3-month peer mentorship intervention compared to a minimally enhanced usual care condition reduces suicide attempts and suicidal ideation among adults at high risk for suicide who have been psychiatrically hospitalized. Secondary effectiveness outcomes include medically serious suicide attempts according to chart review and self-reported self-efficacy to avoid suicide. We also describe suicide risk management, supervision, and fidelity monitoring in the context of Peer Specialist providers and our methods for assessing implementation barriers and facilitators. CONCLUSION: The PREVAIL trial will demonstrate novel methods for incorporating peer providers into a suicide prevention effectiveness trial with high-risk study participants. PREVAIL's hybrid effectiveness-implementation design aims to maximize the likelihood of rapid implementation in the community if shown to be effective.
Authors: Jill M Cyranowski; Nicholas Zill; Rita Bode; Zeeshan Butt; Morgen A R Kelly; Paul A Pilkonis; John M Salsman; David Cella Journal: Health Psychol Date: 2013-03 Impact factor: 4.267
Authors: Ian H Stanley; Melanie A Hom; Megan L Rogers; Christopher R Hagan; Thomas E Joiner Journal: Aging Ment Health Date: 2015-02-19 Impact factor: 3.658
Authors: Guillaume Vaiva; Guillaume Vaiva; François Ducrocq; Philippe Meyer; Daniel Mathieu; Alain Philippe; Christian Libersa; Michel Goudemand Journal: BMJ Date: 2006-05-27
Authors: E Guthrie; N Kapur; K Mackway-Jones; C Chew-Graham; J Moorey; E Mendel; F Marino-Francis; S Sanderson; C Turpin; G Boddy; B Tomenson Journal: BMJ Date: 2001-07-21
Authors: William H Sledge; Martha Lawless; David Sells; Melissa Wieland; Maria J O'Connell; Larry Davidson Journal: Psychiatr Serv Date: 2011-05 Impact factor: 3.084
Authors: Judith A Cook; Mary Ellen Copeland; Jessica A Jonikas; Marie M Hamilton; Lisa A Razzano; Dennis D Grey; Carol B Floyd; Walter B Hudson; Rachel T Macfarlane; Tina M Carter; Sherry Boyd Journal: Schizophr Bull Date: 2011-03-14 Impact factor: 9.306
Authors: Katrina G Witt; Sarah E Hetrick; Gowri Rajaram; Philip Hazell; Tatiana L Taylor Salisbury; Ellen Townsend; Keith Hawton Journal: Cochrane Database Syst Rev Date: 2021-04-22